CD4 and diabetes mellitus: Associations between the aforementioned antiretrovirals and outcomes were assessed using multivariable logistic regression, both unadjusted and adjusted for age, sex at birth, ethnic origin, total comorbidity count (cardiovascular disease; non-AIDS-defining cancer; chronic kidney disease; diabetes mellitus; hypertension; and/or obesity (BMI ≥30 kg/m2), prior AIDS, current CD4+ cell count (categorized <200, 200–499, ≥500 cells/μl), and current HIV-1 viral load (categorized ≤200 or >200 copies/ml).